Skip to main content
Top
Published in: Familial Cancer 1/2007

01-03-2007 | Original Paper

A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy

Authors: Francesca Bianchi, Eva Galizia, Emilio Porfiri, Laura Belvederesi, Romina Catalani, Cristian Loretelli, Raffaella Bracci, Italo Bearzi, Chiara Turchi, Alessandra Viel, Riccardo Cellerino

Published in: Familial Cancer | Issue 1/2007

Login to get access

Abstract

Introduction

Hereditary Non-Polyposis Colorectal Cancer (HNPCC) is an autosomal dominant inherited disease predisposing to the development of colorectal cancers and several other malignancies (endometrium, ovaries, stomach, small bowel, hepatobiliary and urinary tract). HNPCC is caused by germline mutations in any of the MisMatch Repair (MMR) genes. Mutations in MLH1 and MSH2 account for almost 90% of all identified ones. About 15% of mutations identified in MSH2 are missense ones.

Patients and methods

We studied one family, fulfilling Amsterdam II criteria, referred to our Center for genetic counselling. The proband, and some of her relatives, have been investigated for microsatellite instability (MSI), immunohistochemical MMR protein staining and by direct sequencing and Multiplex Ligation-dependent Probe Amplification (MLPA).

Results

All patients carried the same novel MSH2 germline missense mutation (R359S) in exon 7, which determines the substitution of an Arginine, which is a basic amino acid, with a polar Serine residue (R359S). The mutation was associated with lack of expression of MSH2 protein and high microsatellite instability in tumour tissues. The same mutation has been detected in one healthy relative.

Conclusions

The mutation here reported shows a high correlation with phenotype. The mutation is located in an evolutionary conserved domain. Taken together, our findings suggest evidence that the amino acid substitution can be interpreted as pathogenetic.
Literature
1.
go back to reference de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769–780CrossRef de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769–780CrossRef
2.
go back to reference Merg A, Lynch HT, Lynch JF et al (2005) Hereditary colorectal cancer-part II. Curr Probl Surg 42:267–333PubMedCrossRef Merg A, Lynch HT, Lynch JF et al (2005) Hereditary colorectal cancer-part II. Curr Probl Surg 42:267–333PubMedCrossRef
3.
go back to reference Vasen HF, Mecklin JP, Khan PM et al (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425PubMedCrossRef Vasen HF, Mecklin JP, Khan PM et al (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425PubMedCrossRef
4.
go back to reference Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A National Cancer Institute Workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758–1762PubMedCrossRef Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A National Cancer Institute Workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758–1762PubMedCrossRef
5.
go back to reference Umar A, Risinger JI, Hawk ET et al (2004) Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 4:153–158PubMed Umar A, Risinger JI, Hawk ET et al (2004) Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 4:153–158PubMed
6.
go back to reference Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary non-polyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268PubMedCrossRef Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary non-polyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268PubMedCrossRef
7.
go back to reference Pinol V, Castells A, Andreu M et al (2005) Accuracy of revised Bethesda guidelines, microsatellite instability and immunohistochemistry for the identification of patients with hereditary non-polyposis colorectal cancer. JAMA 293:1986–1994PubMedCrossRef Pinol V, Castells A, Andreu M et al (2005) Accuracy of revised Bethesda guidelines, microsatellite instability and immunohistochemistry for the identification of patients with hereditary non-polyposis colorectal cancer. JAMA 293:1986–1994PubMedCrossRef
8.
go back to reference Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development on international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257PubMed Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development on international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257PubMed
9.
go back to reference Strate LL, Syngal S (2005) Hereditary colorectal cancer syndromes. Cancer Causes Control 16:201–213PubMedCrossRef Strate LL, Syngal S (2005) Hereditary colorectal cancer syndromes. Cancer Causes Control 16:201–213PubMedCrossRef
10.
go back to reference Liu B, Parsons R, Papadopoulos N et al (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2:169–174PubMedCrossRef Liu B, Parsons R, Papadopoulos N et al (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2:169–174PubMedCrossRef
11.
go back to reference Peltomaki P, Vasen HF (1997) Mutations predisposing to hereditary non-polyposis coloretal cancer: database and results of a collaborative study. The International Collaborative Group on hereditary non-polyposis colorectal cancer. Gastroenterology 113:1146–1158PubMedCrossRef Peltomaki P, Vasen HF (1997) Mutations predisposing to hereditary non-polyposis coloretal cancer: database and results of a collaborative study. The International Collaborative Group on hereditary non-polyposis colorectal cancer. Gastroenterology 113:1146–1158PubMedCrossRef
12.
13.
go back to reference Syngal S, Fox EA, Li C et al (1999) Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer. JAMA 282:247–253PubMedCrossRef Syngal S, Fox EA, Li C et al (1999) Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer. JAMA 282:247–253PubMedCrossRef
14.
go back to reference Cravo M, Afonso AJ, Lage P et al (2002) Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing. Gut 50:405–412PubMedCrossRef Cravo M, Afonso AJ, Lage P et al (2002) Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing. Gut 50:405–412PubMedCrossRef
15.
go back to reference Scartozzi M, Bianchi F, Rosati S et al (2002) Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 20:1203–1208PubMedCrossRef Scartozzi M, Bianchi F, Rosati S et al (2002) Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 20:1203–1208PubMedCrossRef
16.
go back to reference Marcus VA, Madlensky L, Gryfe R et al (1999) Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 23:1248–1255PubMedCrossRef Marcus VA, Madlensky L, Gryfe R et al (1999) Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 23:1248–1255PubMedCrossRef
17.
go back to reference Syngal S, Fox EA, Eng C et al (2000) Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 37:641–645PubMedCrossRef Syngal S, Fox EA, Eng C et al (2000) Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 37:641–645PubMedCrossRef
18.
go back to reference Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer). N Engl J Med 352:1851–1860PubMedCrossRef Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer). N Engl J Med 352:1851–1860PubMedCrossRef
Metadata
Title
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy
Authors
Francesca Bianchi
Eva Galizia
Emilio Porfiri
Laura Belvederesi
Romina Catalani
Cristian Loretelli
Raffaella Bracci
Italo Bearzi
Chiara Turchi
Alessandra Viel
Riccardo Cellerino
Publication date
01-03-2007
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 1/2007
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-006-9110-z

Other articles of this Issue 1/2007

Familial Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine